Recursion Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 47.19 M | $193.00 M | 18.62% | 10.56% |
| BLACKROCK, INC. | 02/12/2026 | 38.87 M | $158.97 M | 22.45% | 8.70% |
| ARK INVESTMENT MANAGEMENT LLC | 02/11/2026 | 37.32 M | $152.63 M | 11.24% | 8.35% |
| STATE STREET CORP | 02/13/2026 | 25.33 M | $103.62 M | 38.67% | 5.67% |
| BAILLIE GIFFORD & CO | 01/23/2026 | 23.77 M | $97.24 M | -0.85% | 5.32% |
| SOFTBANK GROUP CORP. | 02/17/2026 | 13.64 M | $55.77 M | -7.03% | 3.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 10.93 M | $44.73 M | 13.62% | 2.45% |
| MIC CAPITAL MANAGEMENT UK LLP | 02/17/2026 | 9.64 M | $39.44 M | 0.00% | 2.16% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 6.22 M | $25.44 M | -16.67% | 1.39% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/11/2026 | 6.22 M | $25.38 M | -16.67% | 1.39% |
| DATA COLLECTIVE IV GP, LLC | 02/17/2026 | 5.94 M | $24.30 M | 0.00% | 1.33% |
| NORGES BANK | 02/10/2026 | 5.74 M | $23.47 M | 100.00% | 1.28% |
| MORGAN STANLEY | 02/13/2026 | 5.66 M | $23.14 M | -22.40% | 1.27% |
| EXOR CAPITAL LLP | 02/10/2026 | 4.93 M | $20.17 M | 34.18% | 1.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 4.40 M | $17.98 M | -18.43% | 0.98% |
| CITADEL ADVISORS LLC | 02/17/2026 | 4.23 M | $17.30 M | 213.64% | 0.95% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 4.08 M | $16.67 M | -2.90% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 3.99 M | $16.34 M | 15.95% | 0.89% |
| DCVC OPPORTUNITY FUND II GP, LLC | 02/17/2026 | 3.95 M | $16.16 M | 0.00% | 0.88% |
| UBS GROUP AG | 01/29/2026 | 3.69 M | $15.10 M | -1.65% | 0.83% |
| NORTHERN TRUST CORP | 02/17/2026 | 3.44 M | $14.07 M | 3.08% | 0.77% |
| FMR LLC | 02/17/2026 | 3.24 M | $13.26 M | 0.40% | 0.73% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 3.08 M | $12.58 M | 25.47% | 0.69% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 2.46 M | $10.05 M | 13.70% | 0.55% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 02/12/2026 | 2.40 M | $9.83 M | 35.44% | 0.54% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 2.27 M | $9.27 M | 26.12% | 0.51% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 2.21 M | $9.03 M | 8.53% | 0.49% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.20 M | $9.00 M | 74.49% | 0.49% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.11 M | $8.64 M | 72.58% | 0.47% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.98 M | $8.09 M | 1.84% | 0.44% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.97 M | $8.04 M | 80.30% | 0.44% |
| CAPITAL FUND MANAGEMENT S.A. | 02/17/2026 | 1.78 M | $7.28 M | 145.03% | 0.40% |
| PEAK6 LLC | 03/12/2026 | 1.63 M | $6.67 M | 32.04% | 0.37% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.50 M | $6.12 M | 100.00% | 0.33% |
| BARCLAYS PLC | 02/13/2026 | 1.47 M | $6.01 M | -5.22% | 0.33% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.28 M | $5.23 M | 204.79% | 0.29% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.16 M | $4.75 M | 44.88% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 1.13 M | $4.63 M | -17.38% | 0.25% |
| NUVEEN, LLC | 02/12/2026 | 1.08 M | $4.44 M | -15.00% | 0.24% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 1.08 M | $4.43 M | 858.41% | 0.24% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 968.81 K | $3.96 M | 29.14% | 0.22% |
| COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 02/17/2026 | 941.90 K | $3.85 M | 0.00% | 0.21% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 887.00 K | $3.63 M | 100.00% | 0.20% |
| NATIONAL BANK OF CANADA /FI/ | 02/17/2026 | 875.57 K | $3.58 M | 17,101.85% | 0.20% |
| HSBC HOLDINGS PLC | 03/20/2026 | 818.32 K | $3.37 M | 537.25% | 0.18% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 799.08 K | $3.27 M | 26,959.87% | 0.18% |
| DIADEMA PARTNERS LP | 02/17/2026 | 741.90 K | $3.03 M | 6.23% | 0.17% |
| SWISS NATIONAL BANK | 02/12/2026 | 720.30 K | $2.95 M | 16.07% | 0.16% |
| JANE STREET GROUP, LLC | 02/12/2026 | 701.30 K | $2.87 M | 782.14% | 0.16% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 668.17 K | $2.73 M | 18.80% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Recursion Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 409 institutional investors and hedge funds held shares of Recursion Pharmaceuticals Inc. The most heavily invested institutionals were:
Sumitomo Mitsui Trust Holdings, Inc.: 5.42 M
UBS Group AG: 5.1 M
Bank of New York Mellon Corp: 1.46 M
Nuveen, LLC: 1.16 M
PROFUND ADVISORS LLC: 396,389
COMMONWEALTH EQUITY SERVICES, LLC: 320,991
72.54% of Recursion Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 368.04 M shares in the last 24 months. This purchase volume represents approximately $1.29 B in transactions.